avian
influenza
pandem
pose
potenti
grave
public
health
threat
high
mortal
rate
observ
infect
gener
number
case
singl
hospit
limit
insuffici
statist
result
biomark
predict
diseas
progress
outcom
potenti
lethal
flu
infect
spring
novel
highli
virul
avianorigin
influenza
subtyp
viru
emerg
spread
among
human
eastern
total
peopl
infect
end
alreadi
newli
infect
patient
end
januari
patient
previous
studi
admit
intens
care
among
patient
develop
acut
respiratori
distress
syndrom
ard
associ
high
mortal
intervent
although
extens
therapeut
intervent
employ
includ
antivir
treatment
oxygen
therapi
mechan
ventil
antibiot
glucocorticoid
intraven
immunoglobulin
extracorpor
membran
oxygen
continu
renal
replac
therapi
artifici
liver
support
system
therapi
observ
high
mortal
rate
among
previou
studi
sepsi
aspir
sever
acut
respiratori
syndrom
coronavirusinduc
ard
demonstr
dysfunct
system
ra
involv
molecular
pathogenesi
essenc
angiotensinconvert
enzym
ace
angiotensin
ii
type
receptor
protect
mice
ard
wherea
ace
angiotensin
ii
angiotensin
ii
type
receptor
promot
impair
lung
function
mous
moreov
accompani
show
mice
die
rapidli
infect
recombin
partial
protect
mice
lethal
infect
first
time
gain
access
sampl
larg
cohort
patient
therefor
ask
whether
dysfunct
ra
present
patient
report
highli
posit
linear
associ
plasma
level
angiotensin
ii
patient
diseas
sever
score
acut
physiolog
chronic
health
evalu
ii
apach
ii
angiotensin
ii
level
predict
fatal
outcom
collect
plasma
patient
diagnos
hangzhou
nanj
shanghai
autonom
citi
china
supplementari
fig
tabl
also
collect
plasma
swineorigin
influenza
virusinfect
patient
beij
decemb
februari
supplementari
tabl
presenc
influenza
virus
confirm
pcr
plasma
six
healthi
volunt
china
cdc
consid
high
risk
infect
plasma
coronari
heart
diseas
chd
patient
beij
collect
april
june
characterist
studi
subject
shown
supplementari
tabl
stratifi
distinct
time
point
ill
plasma
obtain
within
first
day
diseas
onset
day
follow
diseas
onset
recoveri
phase
day
diseas
onset
fig
intriguingli
stage
angiotensin
ii
plasma
level
markedli
higher
patient
patient
chd
patient
chd
patient
diagnosi
hypertens
fig
tabl
supplementari
tabl
angiotensin
ii
level
plasma
patient
obtain
first
week
diseas
moder
higher
obtain
healthi
individu
wherea
angiotensin
ii
level
plasma
obtain
time
period
patient
chd
patient
significantli
differ
highrisk
healthi
individu
fig
supplementari
tabl
notabl
angiotensin
ii
level
decreas
patient
plasma
harvest
day
diseas
onset
suggest
angiotensin
ii
level
may
relat
diseas
sever
earli
stage
avian
influenza
infect
fig
supplementari
tabl
investig
whether
chang
angiotensin
ii
level
among
patient
associ
diseas
progress
andor
outcom
analys
angiotensin
ii
level
patient
serial
collect
plasma
sampl
first
second
week
ill
avail
fig
patient
divid
three
group
accord
diseas
outcom
patient
discharg
hospit
within
day
patient
discharg
hospit
day
patient
die
fig
interestingli
group
patient
discharg
hospit
within
day
plasma
angiotensin
ii
level
significantli
decreas
second
week
ill
compar
first
week
howev
group
patient
hospit
longer
period
die
plasma
angiotensin
ii
level
remain
high
second
week
ill
fig
therefor
plasma
angiotensin
ii
level
patient
may
stratifi
diseas
sever
may
predict
diseas
outcom
next
analys
potenti
correl
patient
plasma
angiotensin
ii
level
viral
load
apach
ii
score
mortal
use
sampl
total
patient
sampl
includ
mention
patient
week
week
plasma
sampl
plu
two
patient
week
sampl
patient
week
plasma
sampl
parallel
use
viral
cycl
threshold
ct
valu
patient
patient
sampl
week
patient
sampl
week
calcul
correl
establish
viral
load
collect
pharyng
sampl
day
plasma
collect
patient
first
week
ill
patient
second
week
ill
viral
load
determin
use
ct
valu
haemagglutinin
gene
quantit
realtim
revers
transcriptionpcr
previous
exclud
sampl
ct
valu
indic
neg
viral
load
pearson
correl
analysi
show
plasma
angiotensin
ii
level
inde
neg
correl
viru
ct
valu
thu
posit
correl
viral
load
week
week
ill
supplementari
tabl
data
suggest
elev
angiotensin
ii
level
plasma
patient
harvest
week
diseas
onset
induc
avian
influenza
viru
interestingli
also
discov
high
linear
correl
viral
ct
valu
angiotensin
ii
level
plasma
patient
infect
collect
week
week
diseas
onset
supplementari
tabl
although
angiotensin
ii
level
plasma
patient
significantli
lower
plasma
patient
elev
angiotensin
ii
level
plasma
harvest
first
week
diseas
onset
induc
swineorigin
influenza
viru
supplementari
tabl
apach
ii
score
determin
evalu
diseas
sever
first
day
intens
care
plasma
angiotensin
ii
level
patient
second
week
ill
demonstr
high
significantli
posit
linear
correl
apach
ii
score
wherea
angiotensin
ii
level
first
week
ill
show
weaker
albeit
signific
posit
linear
correl
diseas
sever
fig
plasma
angiotensin
ii
level
patient
posit
correl
patient
apach
ii
score
howev
spearman
rank
coeffici
correl
pass
hypothesi
test
supplementari
fig
result
suggest
potenti
therapeut
strategi
would
involv
decreas
angiotensin
ii
plasma
level
infect
analys
whether
angiotensin
ii
level
link
fatal
outcom
inde
plasma
angiotensin
ii
level
second
week
ill
statist
significantli
higher
group
patient
die
compar
group
discharg
hospit
within
day
fig
swineorigin
influenza
viru
infect
fatal
among
patient
studi
one
patient
die
patient
releas
hospit
within
day
perform
biostatist
analys
confirm
angiotensin
ii
biomark
fatal
outcom
first
use
spss
softwar
calcul
predict
valu
fatal
outcom
supplementari
tabl
addit
angiotensin
ii
also
includ
biomark
infecti
diseas
creactiv
protein
clinic
paramet
pneumonia
sever
index
score
smartcop
area
curv
plasma
angiotensin
ii
level
second
week
ill
among
patient
predict
valu
creactiv
protein
pneumonia
sever
index
score
smartcop
less
signific
angiotensin
ii
fig
supplementari
tabl
data
suggest
angiotensin
ii
level
week
diseas
onset
could
predict
fatal
outcom
also
use
medcalc
softwar
result
supplementari
tabl
sensit
specif
analysi
respect
supplementari
tabl
addit
posit
predict
valu
neg
predict
valu
posit
likelihood
ratio
neg
likelihood
ratio
within
confid
interv
determin
supplementari
tabl
use
logist
regress
analysi
analys
independ
predictor
fatal
outcom
among
patient
infect
angiotensin
ii
level
plasma
harvest
second
week
ill
determin
independ
predictor
among
clinic
paramet
patient
includ
hypertens
tabl
taken
togeth
result
suggest
plasma
angiotensin
ii
level
especi
second
week
ill
indic
diseas
sever
among
patient
posit
associ
mortal
angiotensin
ii
octapeptid
potent
vasopressor
power
stimulu
product
releas
aldosteron
adren
angiotensin
ii
major
substrat
previou
studi
shown
ra
import
role
cardiovascular
diseas
neurodegen
disord
importantli
acut
lung
studi
reveal
first
time
angiotensin
ii
level
human
blood
associ
diseas
sever
may
potenti
predict
patient
mortal
howev
limit
studi
retrospect
natur
studi
addit
potenti
biomark
patient
plasma
need
futur
histor
reason
current
clinic
biomark
predict
fatal
outcom
lethal
viru
infect
addit
lack
suffici
size
cohort
standard
statist
analysi
fatal
outcom
usual
result
multiorgan
failur
therefor
difficult
associ
chang
singl
protein
human
plasma
angiotensin
ii
ra
function
multipl
organ
inde
like
biomark
use
predict
fatal
outcom
lethal
diseas
togeth
accompani
paper
describ
treatment
result
rais
intrigu
possibl
therapi
target
ra
may
repres
viabl
strategi
treat
deadli
diseas
addit
recombin
human
angiotensinconvert
enzym
clinic
trial
angiotensin
ii
lower
drug
includ
ace
inhibitor
angiotensin
ii
receptor
blocker
clinic
futur
studi
necessari
determin
therapeut
effect
propos
ra
target
drug
lethal
viru
infect
patient
recruit
first
affili
hospit
colleg
medicin
zhejiang
univers
jiangsu
provinc
shanghai
citi
patient
recruit
decemb
februari
beij
chaoyang
hospit
capit
medic
univers
six
healthi
volunt
consid
high
risk
infect
chines
center
diseas
control
prevent
china
cdc
chd
patient
includ
chd
patient
diagnosi
hypertens
peke
union
medic
colleg
hospit
pumch
period
recruit
control
clinic
inform
collect
attend
physician
day
plasma
sampl
basic
clinic
inform
treatment
shown
tabl
supplementari
tabl
blood
sampl
collect
use
edtaanticoagul
tube
centrifug
obtain
plasma
patient
plasma
collect
least
twice
hospit
includ
possibl
one
sampl
first
week
one
sampl
second
week
ill
onset
admiss
hospit
patient
sputum
collect
day
use
taqman
realtim
revers
transcriptionpcr
standard
thermal
cycl
condit
detect
gene
specif
influenza
viru
gene
specif
influenza
specimen
store
analysi
inform
written
consent
obtain
particip
enrol
studi
studi
conform
ethic
guidelin
declar
helsinki
approv
institut
review
board
first
affili
hospit
zhejiang
univers
beij
chaoyang
hospit
china
cdc
pumch
plasma
concentr
angiotensin
ii
measur
elisa
accord
manufactur
instruct
rapidbio
lab
usa
experi
perform
biosafeti
level
laboratori
duplic
u
test
use
determin
differ
two
group
wilcoxon
matchedpair
test
employ
assess
differ
first
second
week
diseas
onset
among
patient
pearson
correl
coeffici
spearman
rank
correl
coeffici
use
linear
correl
analysi
calcul
receiv
oper
characterist
curv
predict
analysi
logist
regress
use
independ
predictor
analysi
u
test
wilcoxon
matchedpair
test
pearson
correl
coeffici
analysi
spearman
rank
correl
coeffici
analysi
logist
regress
analysi
perform
spss
window
spss
inc
receiv
oper
characterist
curv
calcul
perform
spss
window
medcalc
softwar
pvalu
consid
statist
signific
cite
articl
huang
f
et
al
angiotensin
ii
plasma
level
link
diseas
sever
predict
fatal
outcom
patient
nat
commun
doi
